Atropine Drops with Special Glasses for Myopia in Children
Part of Eyes & vision clinical trials.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be between 6 and 12 years old.
- Child must have moderate to high myopia (nearsightedness between -3.00 and -9.00 diopters).
- Child must not have used any other myopia control treatments (like special contacts, atropine, or red light therapy) in the past month.
- Child must not have certain eye conditions such as a noticeable eye turn, lazy eye, cataracts, or previous eye surgery.
- Child's best corrected vision with glasses or contacts must be 20/25 or better.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if combining a daily VR vision-training program with low-dose atropine eye drops can slow down or prevent myopia (nearsightedness) from getting worse in children. Participants wear special glasses that help focus light properly and either use atropine alone or atropine plus the VR training.
This study compares different ways to slow down nearsightedness (myopia) in children, including eyedrops and other treatments. It is designed for kids whose vision is getting worse and who are willing to join for 2 years.
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.
This study tests whether atropine eye drops can slow down worsening nearsightedness in children. It is for children whose nearsightedness is getting worse quickly and who have not tried other treatments.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.